James Mongiardo

Company: A-Synaptic Corp.

Job title: Chief Executive Officer

Seminars:

Panel Discussion: Enhancing Bioavailability of CBD Molecules 9:30 am

New CBD derivatives with higher bioavailability Discussing meaningful differences between topical, oral, and transdermal delivery Exploring formulations and penetration enhancersRead more

day: Day Two

Complex Chemically Active Transdermal Emulsion System Systemically Delivering CBD for the Treatment of Dravet syndrome & Lennox-Gastaut syndrome Patients: A Clinical Perspective 9:00 am

Novel chemically active transdermal system used for systemic delivery of therapeutic concentrations of CBD and THC Review of in vivo patient bioavailability data including blood concentrations curves for delivery of CBD and THC over a 12-hour period Review of in vivo patient response in CBD clinical trials to treat Dravet syndrome and Lennox-Gastaut syndrome patientsRead more

day: Day Two